• Amesite posted a net loss of USD 3.1 million for fiscal 2026, narrowing from a net loss of USD 3.62 million.
• Revenue more than doubled to USD 364,777 from USD 110,459, mainly from B2B license fees tied to the NurseMagic app.
• General and administrative expense was USD 2.51 million, little changed from USD 2.48 million.
• Technology and content development expense fell 11.22% to USD 613,578, while sales and marketing expense dropped 29.54% to USD 384,041.
• Cash totaled USD 2.4 million at June 30, 2026, and management said conditions raise substantial doubt about going concern.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amesite Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-102676), on September 23, 2026, and is solely responsible for the information contained therein.